SCHEMBL23633015

SCHEMBL23633015

COCOc1cccc(C=O)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
HPGD P15428 2/20 0.46
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TLR2 O60603 1/20 0.45
ERN1 O75460 1/20 0.45
TLR1 Q15399 1/20 0.45
TLR6 Q9Y2C9 1/20 0.45
CLCN2 P51788 1/20 0.39
LMNA P02545 2/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
SRC P12931 1/20 0.39
PTPN1 P18031 1/20 0.38
KDM4E B2RXH2 1/20 0.38
POLB P06746 1/20 0.38
RECQL P46063 1/20 0.38
CA1 P00915 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1749088 0.83 ALDH1A1 (0.48) ALDH1A1HPGDHTTSMN1; SMN2TLR2
SCHEMBL1243967 0.82 ALDH1A1 (0.68) ALDH1A1HPGDHTTSMN1; SMN2TLR2
SCHEMBL3214106 0.81 ALDH1A1 (0.47) ALDH1A1HPGDHTTSMN1; SMN2TLR2
SCHEMBL22804095 0.81 TLR2 (0.50) ALDH1A1HPGDHTTSMN1; SMN2TLR2
SCHEMBL63899 0.80 ERN1 (0.61) ALDH1A1HPGDHTTSMN1; SMN2TLR2
SCHEMBL13035548 0.80 ALDH1A1 (0.46) ALDH1A1HPGDHTTSMN1; SMN2TLR2
SCHEMBL4683638 0.80 CA1 (0.53) ALDH1A1HPGDHTTSMN1; SMN2TLR2
SCHEMBL19511461 0.80 ERN1 (0.67) ALDH1A1HPGDHTTSMN1; SMN2TLR2
SCHEMBL29593979 0.80 CLCN2 (0.37) HPGDTLR2ERN1TLR1TLR6
SCHEMBL23633049 0.80 CLCN2 (0.37) HPGDTLR2ERN1TLR1TLR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552811-B2 Immunosuppressant, and preparation method therefor and use thereof ABBISKO THERAPEUTICS CO., LTD. (CN) 2026-02-17 US disclosed
US-12473282-B2 Biphenyl fluorine double bond derivative, preparation method therefor, and pharmaceutical application thereof ABBISKO THERAPEUTICS CO., LTD. (CN) 2025-11-18 US disclosed
WO-2025029075-A1 NOVEL BIPHENYL DERIVATIVE AS PD-L1 INHIBITOR (주)아이랩 2025-02-06 WO disclosed
US-20230234970-A1 IMMUNOSUPPRESSANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF ABBISKO THERAPEUTICS CO., LTD. (CN) 2023-07-27 US disclosed
EP-4174066-A1 IMMUNOSUPPRESSANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2023-05-03 EP disclosed
US-20230014651-A1 BIPHENYL FLUORINE DOUBLE BOND DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF ABBISKO THERAPEUTICS CO., LTD. (CN) 2023-01-19 US disclosed
CN-115605475-A Immunosuppressant, preparation method and application thereof 上海和誉生物医药科技有限公司(CN) 2023-01-13 CN disclosed
EP-4089091-A1 BIPHENYL FLUORINE DOUBLE BOND DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2022-11-16 EP disclosed
CN-114502556-A Biphenyl fluoro double bond derivative and preparation method and pharmaceutical application thereof 上海和誉生物医药科技有限公司 2022-05-13 CN disclosed
WO-2021254005-A1 IMMUNOSUPPRESSANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海和誉生物医药科技有限公司 2021-12-23 WO disclosed
WO-2021139647-A1 BIPHENYL FLUORINE DOUBLE BOND DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF 上海和誉生物医药科技有限公司 2021-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552811-B2 Immunosuppressant, and preparation method therefor and use thereof CD274, PDCD1, PDCD1LG2 ALDH1A1 341/4885HPGD 434/4885HTT 4192/4885
US-12473282-B2 Biphenyl fluorine double bond derivative, preparation method therefor, and pharmaceutical application thereof PDCD1, CD274, PDCD1LG2 ALDH1A1 171/4885HPGD 1702/4885HTT 3776/4885
US-20230234970-A1 IMMUNOSUPPRESSANT, AND PREPARATION METHOD THEREFOR AND USE THEREOF CD274, PDCD1, PDCD1LG2 ALDH1A1 106/4885HPGD 513/4885HTT 3993/4885
US-20230014651-A1 BIPHENYL FLUORINE DOUBLE BOND DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATION THEREOF PDCD1, CD274, PDCD1LG2 ALDH1A1 171/4885HPGD 1702/4885HTT 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.